<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJEMD</journal-id><journal-title-group><journal-title>Open Journal of Endocrine and Metabolic Diseases</journal-title></journal-title-group><issn pub-type="epub">2165-7424</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojemd.2012.24008</article-id><article-id pub-id-type="publisher-id">OJEMD-24454</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Difficulties in Recruitment for a Randomised Controlled Trial of Lifestyle Intervention for Type 2 Diabetes: Implications for Diabetes Management
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>eorge</surname><given-names>A. Jelinek</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Emily</surname><given-names>Hadgkiss</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Craig</surname><given-names>Hassed</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bernard</surname><given-names>Crimmins</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Peter</surname><given-names>Schattner</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Danny</surname><given-names>Liew</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rick</surname><given-names>Kausman</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Warrick</surname><given-names>J. Inder</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Siegfried</surname><given-names>Gutbrod</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tracey</surname><given-names>J. Weiland</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of General Practice, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia</addr-line></aff><aff id="aff7"><addr-line>Formerly Department of Endocrinology, St Vincent’s Hospital, Melbourne, Australia</addr-line></aff><aff id="aff6"><addr-line>The Butterfly Foundation, Malvern, Australia</addr-line></aff><aff id="aff4"><addr-line>East Bentleigh General Practice, Melbourne, Australia</addr-line></aff><aff id="aff5"><addr-line>Department of Medicine, Faculty of Medicine and Health Sciences, The University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia</addr-line></aff><aff id="aff8"><addr-line>The Gawler Foundation, Yarra Junction, Australia</addr-line></aff><aff id="aff3"><addr-line>Manningham General Practice, Melbourne, Australia</addr-line></aff><aff id="aff1"><addr-line>Emergency Practice Innovation Centre, St Vincent’s Hospital, Melbourne, Australia</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>George.jelinek@svhm.org.au(EAJ)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>11</month><year>2012</year></pub-date><volume>02</volume><issue>04</issue><fpage>53</fpage><lpage>57</lpage><history><date date-type="received"><day>September</day>	<month>22,</month>	<year>2012</year></date><date date-type="rev-recd"><day>October</day>	<month>15,</month>	<year>2012</year>	</date><date date-type="accepted"><day>November</day>	<month>5,</month>	<year>2012</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: To report our experience of attempting a randomised controlled trial of an intensive lifestyle intervention for early type 2 diabetes delivered in a residential setting. Methods: We established a trial requiring 84 participants (46 standard care and 38 intervention) to detect a 1% difference in HbA1c between intervention and control groups at 12 months, allowing for attrition. Ethics approval was obtained from Monash University. Results: The study was abandoned after five months of consistent promotion due to recruitment failure (four subjects recruited). Conclusion: It appears to be difficult for patients with diabetes to commit to a live-in period of education regarding lifestyle modification as a means of treating the illness. We recommend better education of patients and their doctors about the potential health benefits of lifestyle change to manage type 2 diabetes, and further research into novel methods of delivering lifestyle advice which are both effective and sustainable.
 
</p></abstract><kwd-group><kwd>Type 2 Diabetes Mellitus; Randomised Controlled Trial; Management; Lifestyle; Risk Factors</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Polyurethane foams are made by mixing an isocyanate and a polyol component [<xref ref-type="bibr" rid="scirp.24454-ref1">1</xref>]. Normally the polyol stream contains additives to achieve the end properties, among these additives are blowing agents, catalysts and surfactants. Silicone surfactant plays an important role in flexible polyurethane foam through decrement of the surface tension. Copolymers of a polydimethylsiloxane are well known and used as surfactants in polyurethane industry. Foam behaviour or foamability is a complex phenomena related with the composition and chemical structure of the amphiphile and depends on many factors such as type of the foam films, surface forces, disjoining pressure, temperature, kinetics of thinning and film rupture, surface and bulk rheology [2,3]. The mechanical properties of the cured polyurethane foam as air permeability and cell size are affected significantly by the structure of the silicone surfactant used in the formulation. Surfactants based Polydimethylsiloxane (PDMS) help with nucleation and in stabilizing foaming mixtures. G. Besmans, L. Colman and R. Vandensande used the maximum bubble pressure method to measure dynamic behavior of these silicone surfactants (PDMS) in the viscous polyol medium, a method which allowed fast screening of novel surfactants [<xref ref-type="bibr" rid="scirp.24454-ref4">4</xref>], that has been proved for measuring the dynamic response of surfactants in aqueous media. According to G. Besmans, L. Colman and R. Vandensande, dynamic surface tension response was measured in methyl capped polyethylene glycol PEG (MW 500 from ICI) using a surfactant loading of 0.1% by weight. Surfactants were obtained from Goldschmidt AG, Osi, and Air Products.</p><p>Commercially polydimethylsiloxane based surfactants are of a polymeric nature with a natural spread of molecular weight. The exact structure is part of the proprietary knowledge of the surfactant suppliers (<xref ref-type="fig" rid="fig1">Figure 1</xref>), but can be described with the formula where D is dimethylsiloxane and D is methylsiloxane with polyoxyalkylene, susbstitute R is composed of polyethylene oxide and polypropylene oxide [<xref ref-type="bibr" rid="scirp.24454-ref4">4</xref>].</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>Analytical grade nonyl phenol ethoxylates were purchased from Sigma and used with no further purification.</p><p>Silicone Tegostab BF-2370 provided by Goldschmidt AG (<xref ref-type="fig" rid="fig2">Figure 2</xref>), was used as surfactant with a molecular mass of 8800 g/mol [<xref ref-type="bibr" rid="scirp.24454-ref5">5</xref>]. The polyol polypropylene glycol was supplied by Sigma Aldrich, molecular mass is 2700 g/mol. Pluronic L61 (BASF) is a block copolymer, the average molecular mass is 2000 g/mol, consisting of 10% ethylene oxide and 90% propylene oxide.</p><p>Surfactant-polyol mixtures were prepared at controlled temperature of 30˚C. The samples were placed in a thermostated vessel during the surface tension measurements and the temperature was regulated (within &#177; 0.1˚C).</p><p>Surface tension methods A dynamic method for surface tension was chosen, the maximum bubble pressure method displayes surface tension based on instantaneous bubble formation [6-8]. This is a dynamic method selected for surface tension measurements due to polyurethane foam formulation taking seconds during its production.</p><p>Surface tension vs composition was measured using QC3000 SensaDyne Surface Tensiometer (within &#177;0.1 dyne/cm) fitted with a bath (Haake K20/DC30) allowing to control the temperature (within &#177;0.1˚C). An inert process gas (nitrogen or dry air) is bubbled slowly through two probes of different radio that are immersed in a test fluid. The bubbling of the nitrogen through the probes produces a differential pressure signal (ΔP) which is directly related to the fluid surface tension (σ).</p><p>The Young-Laplace equation rules the relation among curvature, surface energy and pressure difference between two phases; it has been used to describe spherical and non spherical shapes either in the absence or under the influenece of an external field. The general expression for the mechanical equilibrium between phases separated by spherical surface is</p><disp-formula id="scirp.24454-formula1713"><label>(1)</label><graphic position="anchor" xlink:href="1-1230112\05c7e8e2-504e-41a6-ad69-5fbecf1a1636.jpg"  xlink:type="simple"/></disp-formula><p>where r is the sphere radius and DP is the difference in the pressure between phases. The difference in the pressure P<sub>2</sub> at the large probe from the pressure P<sub>1</sub> at the small probe results in a differential pressure equation keeping the two probes at the approximate same immersion depth cancelling the effects of liquid level (<xref ref-type="fig" rid="fig3">Figure 3</xref>), and the additional variation in the hydrostatic pressure caused by the gravitational field effect.</p><disp-formula id="scirp.24454-formula1714"><label>(2)</label><graphic position="anchor" xlink:href="1-1230112\2224aee4-b2d2-4e2f-bd50-c40e764e3f10.jpg"  xlink:type="simple"/></disp-formula><p>Foam formation test Foam was produced using a glass column of 1000 ml fitted at the bottom with a porous glass disk. Samples of the polydimethylsiloxane dispersions were carefully pured into the column and foam was produced at a constant temperature of 30˚C by passing gas trough the porous glass (pore diameter 0.2 μm) at a controlled flux between 20 and 60 ml/min during ten minutes (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Surfactant concentration ranged between 0.05 and 1.2 wt%. Results were expressed as foamability or the volume produced by a weight fraction of surfactant in polyol.</p></sec><sec id="s3"><title>3. Results and discussion</title><p>Although surface properties for both kinds of polyols were similar (<xref ref-type="fig" rid="fig5">Figure 5</xref>), foaming behaviour presented differences (<xref ref-type="fig" rid="fig6">Figure 6</xref>). The foaming behaviour increased with concentration, with a maximum around the critical concentration and then decreased; an expected behaviour for transient foams.</p><p>Some works have been published describing methods to calculate equilibrium constants of molecular complexes in aqueous solution or to predict activity coefficients at infinite dilution from surface tension data [9, 10]. In this line it has been recently developed a model [<xref ref-type="bibr" rid="scirp.24454-ref11">11</xref>], able to describe the dependence of the surface tension on the concentration for a wide variety of solutions with different behavior (Figures 7 and 8), the model has been named Langmuir modified [<xref ref-type="bibr" rid="scirp.24454-ref12">12</xref>], that can be expressed as</p><disp-formula id="scirp.24454-formula1715"><label>(3)</label><graphic position="anchor" xlink:href="1-1230112\86f401df-67d7-476b-9dd7-6ea8441099cc.jpg"  xlink:type="simple"/></disp-formula><p>where p is surface pressure, Γ is the excess surface concentration and is equall to the reciprocal area, G<sub>s</sub> is the maximum surface concentration, R is the universal gas constant, T is the absolute temperature and β is a measure of the lyophobicity, so, based on the Langmuir isotherm, where θ is the surface coverage,<img src="1-1230112\c28b5736-43df-4551-9b26-8f58e721e970.jpg" />;</p><disp-formula id="scirp.24454-formula1716"><label>(4)</label><graphic position="anchor" xlink:href="1-1230112\a2ebd81d-c538-4d66-ab26-d25c7e25af56.jpg"  xlink:type="simple"/></disp-formula><p>The Gibbs adsorption isotherm allows us to transform an isotherm to a surface equation of state [<xref ref-type="bibr" rid="scirp.24454-ref13">13</xref>]. The Langmuir isotherm in fluid-fluid interfaces, coupled with the Gibbs equation, leads to;</p><disp-formula id="scirp.24454-formula1717"><label>(5)</label><graphic position="anchor" xlink:href="1-1230112\95bb0c15-8572-4bd8-b1d6-1f4b778d06c6.jpg"  xlink:type="simple"/></disp-formula><p>The combination of Equations (4) and (5) and integral form leads to the corresponding surface equation of state SEOS</p><disp-formula id="scirp.24454-formula1718"><label>(6)</label><graphic position="anchor" xlink:href="1-1230112\e41f4ab0-f54c-46ba-b888-1fad1a45c187.jpg"  xlink:type="simple"/></disp-formula><p>from the Lagmuir-Frumkin equation;</p><disp-formula id="scirp.24454-formula1719"><label>(7)</label><graphic position="anchor" xlink:href="1-1230112\1e06bcfc-cda5-4727-94fd-e04e94194bfd.jpg"  xlink:type="simple"/></disp-formula><p>Equation (7) does not include atractive effects, so is proposed a general function f(θ);</p><disp-formula id="scirp.24454-formula1720"><label>(8)</label><graphic position="anchor" xlink:href="1-1230112\973fadec-3742-4190-9673-53de448bf3f1.jpg"  xlink:type="simple"/></disp-formula><p>That can be expressed as series expansion;</p><disp-formula id="scirp.24454-formula1721"><label>(9)</label><graphic position="anchor" xlink:href="1-1230112\911aeacc-90b3-47bf-a8bc-2fca75672925.jpg"  xlink:type="simple"/></disp-formula><p>Obtaining the final Equation (3) to which the experimental data are fitted;</p><p><img src="1-1230112\b8350f65-0fb8-4c48-96ef-77b7531f4079.jpg" /></p><p>Polidimethylsiloxanes form transient foams in polyols, meaning that the foam is present as long as the gas flux is present and depended on concentration. Pluronic L61 showed lower foamability with bubbles breaking up as soon as the gas flux was interrupted. On the other hand Polypropylene glycol showed better foamability with a maximum that coincides with the critical concentration just as predicted for transient foams.</p><p>Gibbs elasticity modulus is closely related to foamability and is expressed as;</p><disp-formula id="scirp.24454-formula1722"><label>(10)</label><graphic position="anchor" xlink:href="1-1230112\1bab4bc4-6ec2-454f-94cb-8b4a41caf732.jpg"  xlink:type="simple"/></disp-formula><p>Г is the surface concentration and is equal to the reciprocal of the molecular area;</p><disp-formula id="scirp.24454-formula1723"><label>(11)</label><graphic position="anchor" xlink:href="1-1230112\ac029792-5ed6-4a21-9bee-48efe21681d5.jpg"  xlink:type="simple"/></disp-formula><p>leads to the equation;</p><disp-formula id="scirp.24454-formula1724"><label>(12)</label><graphic position="anchor" xlink:href="1-1230112\912cdc61-a834-473b-a795-cc8041938f1e.jpg"  xlink:type="simple"/></disp-formula><p>Surface tension expressed as surface pressure;</p><disp-formula id="scirp.24454-formula1725"><label>(13)</label><graphic position="anchor" xlink:href="1-1230112\cbf7e00a-ee33-4e94-97d5-c5ce8fd59226.jpg"  xlink:type="simple"/></disp-formula><p>Expressions (12) and (13) can be substituted in Equation (10) providing;</p><disp-formula id="scirp.24454-formula1726"><label>(14)</label><graphic position="anchor" xlink:href="1-1230112\59db9eaa-adc1-4d18-a5ee-4d03d7bf727d.jpg"  xlink:type="simple"/></disp-formula><p>Surface pressure can be used instead of surface tension and the associated area changed for specific area, thus</p><disp-formula id="scirp.24454-formula1727"><label>(15)</label><graphic position="anchor" xlink:href="1-1230112\0c364bc8-3270-4362-b45b-ca813c2d5be4.jpg"  xlink:type="simple"/></disp-formula><p>That can be expressed as;</p><disp-formula id="scirp.24454-formula1728"><label>(16)</label><graphic position="anchor" xlink:href="1-1230112\4db656ca-f4c4-47c0-bdc6-da1a564168db.jpg"  xlink:type="simple"/></disp-formula><p>From Gibbs adsorption equation;</p><disp-formula id="scirp.24454-formula1729"><label>(17)</label><graphic position="anchor" xlink:href="1-1230112\e5e5059c-8964-496e-aacd-69b715f43c40.jpg"  xlink:type="simple"/></disp-formula><p>Surface coverage can be used instead of surface tension, so</p><disp-formula id="scirp.24454-formula1730"><label>(18)</label><graphic position="anchor" xlink:href="1-1230112\051ccfc4-9632-4329-b51a-30f4f35ee2e6.jpg"  xlink:type="simple"/></disp-formula><p>The first derivative with respect to mol fraction is;</p><disp-formula id="scirp.24454-formula1731"><label>(19)</label><graphic position="anchor" xlink:href="1-1230112\3f1c3990-d454-4a90-83c4-037ee5391218.jpg"  xlink:type="simple"/></disp-formula><p>By substituing relationships (18) and (19) into Equation (16) to express Gibbs elasticity modulus as;</p><disp-formula id="scirp.24454-formula1732"><label>(20)</label><graphic position="anchor" xlink:href="1-1230112\780b91a3-8897-4151-b5d8-3fdb7975752e.jpg"  xlink:type="simple"/></disp-formula><p>The combination of Equation (3) and (20) leads to</p><disp-formula id="scirp.24454-formula1733"><label>(21)</label><graphic position="anchor" xlink:href="1-1230112\ab1bc832-1d10-4e23-bf7c-7b09f607f712.jpg"  xlink:type="simple"/></disp-formula><p>Equation (21) can be expressed as follows;</p><disp-formula id="scirp.24454-formula1734"><label>(22)</label><graphic position="anchor" xlink:href="1-1230112\a0588943-606c-4415-ad35-daaa3d35ee2f.jpg"  xlink:type="simple"/></disp-formula><p>The bulk concentration x is related to the surface concentration θ and the foam goes to maximum (<xref ref-type="fig" rid="fig9">Figure 9</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>0), it happens when x= 1/b ; beyond the critical concentration, the surface coverage is completed and the surface pressure remains constant thus Gibbs elasticity modulus goes to zero and the foam decays [14-17]. The concentration level where the maximum foam volume was obtained agrees with the concentration level on polyurethane foam formulations.</p></sec><sec id="s4"><title>4. Conclusion</title><p>It has been shown that it is possible to characterize the surface tension of polydimethylsiloxane based surfactants in viscous model systems of a polyurethane foam forming medium. Even though both polyols don’t share same characteristics, the surface tension equilibrium was very similar when PDMS is involved as surfactant. However Pluronic L61 presented poor foaming behaviour explained by the rectification process ocurring along the foam column. PDMS showed transient foam behaviour with maximum foamability around concentration level</p><p>used in polyurethane foam formulations. Polypropylene glycol presented better foaming properties compared to Pluronic L61 which had poor foaming behaviour explained by the rectification process ocurring along the foam causing Pluronic a lower capability to re-establish the surface concentration limiting the adsorption to the newly created surfaces. Even though foam is a dispersed system and hence out of equilibrium, the hypothesis of local chemical equilibrium between lamellar solution and foam’s surface shows a proximity towards equilibrium conditions and allows for the thermodynamic description of elasticity; which for the purpose of this work was referred to foamability. The equation presented allows a direct relation to the Gibbs adsorption equation and is applicable for transient foams to predict concentration stability zone for polyurethane flexible systems that involve polidymethylsiloxane-poliol mixtures, where foamability decreases beyond a critical concentration. Foamability, or the foam volume produced by an amphiphile in a viscous medium like a poliol at a given concentration, is satisfactorily described by means of the Gibbs elasticity modulus (ε) presented in terms of the first and second derivatives of surface pressure and the bulk concentration.</p></sec><sec id="s5"><title>5. Acknowledgements</title><p>This work was supported by Direcci&#243;n General de Administraci&#243;n del Personal Acad&#233;mico (DGAPA) under the project PAPIIT-IT118711.</p></sec><sec id="s6"><title>REFERENCES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.24454-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">D. Dunstan, S. Colagiuri, P. Zimmet, et al., “The Rising Prevalence of Diabetes and Impaired Glucose Tolerance: The Australian Diabetes, Obesity and Lifestyle Study,” Diabetes Care, Vol. 25, No. 5, 2002, pp. 829-834. 
doi:10.2337/diacare.25.5.829</mixed-citation></ref><ref id="scirp.24454-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">E. L. M. Barr, D. J. Magliano, P. Z. Zimmet, et al., “The Australian Diabetes, Obesity and Lifestyle Study. Tracking the Accelerating Epidemic: Its Causes and Outcomes,” International Diabetes Institute, Melbourne, 2006.</mixed-citation></ref><ref id="scirp.24454-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">S. F. Wetterhall, D. R. Olson, F. DeStefano, et al., “Trends in Diabetes and Diabetic Complications, 1980-1987,” Diabetes Care, Vol. 15, No. 8, 1992, pp. 960-967. doi:10.2337/diacare.15.8.960</mixed-citation></ref><ref id="scirp.24454-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">A. C. Powers, “Diabetes Mellitus. Harrison’s Principles of Internal Medicine,” The McGraw-Hill Companies, Inc., Ohio, 2005.</mixed-citation></ref><ref id="scirp.24454-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">S. Colagiuri, R. Colagiuri, B. Conway, et al., “DiabCo$t Australia: Assessing the Burden of Type 2 Diabetes in Australia,” Diabetes Australia, Canberra, 2003.</mixed-citation></ref><ref id="scirp.24454-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">D. L. Kasper, E. Braunwald, A. S. Fauci, et al., “Harrison’s Principles of Internal Medicine,” 16th Edition, The McGraw-Hill Companies, Inc., New York, 2005.</mixed-citation></ref><ref id="scirp.24454-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">P. Zimmet, K. G. M. M. Alberti, J. Shaw, “Global and Societal Implications of the Diabetes Epidemic,” Nature, Vol. 414, No. 6865, 2001, pp. 782-787.  
doi:10.1038/414782a</mixed-citation></ref><ref id="scirp.24454-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Australian Centre for Diabetes Strategies, “National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus. Prince of Wales Hospital,” National Health and Medical Research Council, Sydney, 2005.</mixed-citation></ref><ref id="scirp.24454-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">J. Tuomilehto and J. Lindstrom, “The Principal Trials for Prevention of Type 2 Diabetes Have Now Confirmed That Type 2 Diabetes Can Be Prevented by Life Style Changes. Prevention of Type 2 Diabetes by Life Style,” Journees Annuelles de Diabetologie de Hotel-Dieu, 2003, pp. 77-89.</mixed-citation></ref><ref id="scirp.24454-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">C. L. Gillies, K. R. Abrams, P. C. Lambert, et al., “Pharmacological and Lifestyle Interventions to Prevent or Delay Type 2 Diabetes in People with Impaired Glucose Tolerance: Systematic Review and Meta-Analysis,” (BMJ) British Medical Journal, Vol. 334, No. 7588, 2007, pp. 334-299. doi:10.1136/bmj.39063.689375.55</mixed-citation></ref><ref id="scirp.24454-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">A. Yuen, Y. Sugeng, T. J. Weiland, et al., “Lifestyle and Medication Interventions for the Prevention and Delay of Type 2 Diabetes in Pre-diabetes: A Systematic Review of Randomised Controlled Trials,” Australian and New Zealand Journal of Public Health, Vol. 34, No. 2, 2010, pp. 172-178.</mixed-citation></ref><ref id="scirp.24454-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">S. L. Norris, M. M. Engelgau and K. M. Narayan, “Effectiveness of Self-Management Training in Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials,” Diabetes Care, Vol. 24, No. 3, 2001, pp. 561-587.  
doi:10.2337/diacare.24.3.561</mixed-citation></ref><ref id="scirp.24454-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">P. Gaede, P. Vedel, H. H. Parving, et al., “Intensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus and Microalbuminuria: The Steno Type 2 Randomised Study,” Lancet, Vol. 353, No. 9153, 1999, pp. 617-622. doi:10.1016/S0140-6736(98)07368-1</mixed-citation></ref><ref id="scirp.24454-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">J. S. Cramer, R. F. Sibley, D. P. Bartlett, et al., “An Adaptation of the Diabetes Prevention Program for Use with High-Risk, Minority Patients with Type 2 Diabetes,” Diabetes Education, Vol. 33, No. 3, 2007, pp. 503-508. 
doi:10.1177/0145721707301680</mixed-citation></ref><ref id="scirp.24454-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">M. J. Davies, S. Heller, T. C. Skinner, et al., “Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) Programme for People with Newly Diagnosed Type 2 Diabetes: Cluster Randomised Controlled Trial,” (BMJ) British Medical Journal, Vol. 336, No. , 2008, pp. 491-495. 
doi:10.1136/bmj.39474.922025.BE</mixed-citation></ref><ref id="scirp.24454-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">T. A. Deakin, J. E. Cade, R. Williams, et al., “Structured Patient Education: The Diabetes X-PERT Programme Makes a Difference,” Diabetic Medicine, Vol. 23, No. 9, 2006, pp. 944-954.  
doi:10.1111/j.1464-5491.2006.01906.x</mixed-citation></ref><ref id="scirp.24454-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">S. H. Kim, S. J. Lee, E. S. Kang, et al., “Effects of Lifestyle Modification on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with Type 2 Diabetes Mellitus,” Metabolism, Vol. 55, No. 8, 2006, pp. 1053-1059. doi:10.1016/j.metabol.2006.03.017</mixed-citation></ref><ref id="scirp.24454-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">C. K. Roberts and R. J. Barnard, “Effects of Exercise and Diet on Chronic Disease,” Journal of Applied Physiology, Vol. 98, No. 1, 2005, pp. 3-30. 
doi:10.1152/japplphysiol.00852.2004</mixed-citation></ref><ref id="scirp.24454-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">M. Trento, P. Passera, M. Bajardi, et al., “Lifestyle Intervention by Group Care Prevents Deterioration of Type II Diabetes: A 4-Year Randomized Controlled Clinical Trial,” Diabetologia, Vol. 45, No. 9, 2001, pp. 1231-1239. 
doi:10.1007/s00125-002-0904-8</mixed-citation></ref><ref id="scirp.24454-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">G. A. Jelinek, T. J. Weiland, G. Moore, et al., “Screening for Type 2 Diabetes with Random Finger-Prick Glucose and Bedside HbA1c in an Australian Emergency Department,” Emergency Medicine &amp; Australasian, Vol. 22, No. 5, 2010, pp. 427-434. 
doi:10.1111/j.1742-6723.2010.01333.x</mixed-citation></ref><ref id="scirp.24454-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">T. J. Weiland, M. Nguyen and G. A. Jelinek, “Illness Perception and Knowledge with Regard to Prediabetes and Type 2 Diabetes: A Pilot Study of Emergency Department Patients and Staff,” European Journal of Emergency Medicine, Vol. 19, No. 6, 2011, pp. 353-358.</mixed-citation></ref><ref id="scirp.24454-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Training in Flexible, Intensive Insulin Management to Enable Dietary Freedom in People with Type 1 Diabetes: Dose Adjustment for Normal Eating (DAFNE) Randomised Controlled Trial,” (BMJ) British Medical Journal, Vol. 325, 2002, p. 746.  
doi:10.1136/bmj.325.7367.746</mixed-citation></ref><ref id="scirp.24454-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Y. Ohkubo, H. Kishikawa, E. Araki, et al., “Intensive Insulin Therapy Prevents the Progression of Diabetic Microvascular Complications in Japanese Patients with Non-Insulin-Dependent Diabetes Mellitus: A Randomized Prospective 6-Year Study,” Diabetes Research and Clinical Practice, Vol. 28, No. 2, 1995, pp. 103-117.  
doi:10.1016/0168-8227(95)01064-K</mixed-citation></ref><ref id="scirp.24454-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">J. P. Burke, S. M. Haffner, S. P. Gaskill, et al., “Reversion from Type 2 Diabetes to Nondiabetic Status. Influence of the 1997 American Diabetes Association Criteria,” Diabetes Care, Vol. 21, No. 8, 1998, pp. 1266-1270.  
doi:10.2337/diacare.21.8.1266</mixed-citation></ref><ref id="scirp.24454-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">E. Hadgkiss, G. Jelinek, T. Weiland, et al., “Health-Related Quality of Life Outcomes at 1 and 5 Years after a Residential Retreat Promoting Lifestyle Modification for People with Multiple Sclerosis,” Neurological Sciences, in press, 2012.</mixed-citation></ref><ref id="scirp.24454-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">M. P. Li, G. A. Jelinek, T. J. Weiland, et al., “Effect of a Residential Retreat Promoting Lifestyle Modifications on Health-Related Quality of Life in People with Multiple Sclerosis,” Quality in Primary Care, Vol. 18, No. 8, 2010, pp. 379-389.</mixed-citation></ref><ref id="scirp.24454-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">S. Colagiuri, D. Davies, S. Girgis, et al., “National Evidence Based Guideline for Case Detection and Diagnosis of Type 2 Diabetes,” Diabetes Australia, Canberra, 2009.</mixed-citation></ref><ref id="scirp.24454-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">W. C. Knowler, E. Barrett-Connor, S. E. Fowler, et al., “Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin,” New England Journal of Medicine, Vol. 346, No. 6, 2002, pp. 393-403.  
doi:10.1056/NEJMoa012512</mixed-citation></ref></ref-list></back></article>